Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
LIPO holding history
Lipella Pharmaceuticals Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LIPO overviewAll 13F holders of LIPOFull Q4 2025 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −34,520−100.0% | Sold out | Holders |
| Q3 2024 | 34,520 | $16.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 34,520 | $15.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 34,520 | $23.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 34,520 | $35.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 34,520 | $51.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 34,520 | $73.9K | <0.1% | −2,554−6.9% | Reduced | Holders |
| Q1 2023 | 37,074 | $72.3K | <0.1% | +37,074 | New | Holders |